Английская Википедия:Dermatologic and Ophthalmic Drugs Advisory Committee
Материал из Онлайн справочника
The Dermatologic And Ophthalmic Drugs Advisory Committee (DODAC) receives requests for technical and clinical evaluation of new drugs by the U.S. Food and Drug Administration (FDA). The committee, consisting of members from academic and clinical dermatology, ophthalmology, biostatistics, the general public, and the pharmaceutical industry, makes non-binding recommendations to both the CDER and CBER divisions of the FDA about the advisability of approving new medications to treat dermatologic and ophthalmic conditions.
References
External links
- Dermatologic And Ophthalmic Drugs Advisory Committee, official webpage: https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/DermatologicandOphthalmicDrugsAdvisoryCommittee/default.htm
- FDA Advisory Committees Calendar (including DODAC): https://www.fda.gov/AdvisoryCommittees/Calendar/default.htm
Категории:
- Английская Википедия
- Food and Drug Administration
- National agencies for drug regulation
- Regulators of biotechnology products
- Pharmacy organizations in the United States
- Страницы, где используется шаблон "Навигационная таблица/Телепорт"
- Страницы с телепортом
- Википедия
- Статья из Википедии
- Статья из Английской Википедии
